PlainRecalls
FDA Drug Moderate Class II Ongoing

Deferasirox Tablets for Oral Suspension, 500mg, 30-count bottle, Rx only, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, Product of India, NDC 68462-496-30

Reported: November 15, 2023 Initiated: October 20, 2023 #D-0095-2024

Product Description

Deferasirox Tablets for Oral Suspension, 500mg, 30-count bottle, Rx only, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, Product of India, NDC 68462-496-30

Reason for Recall

Failed Dissolution Specifications

Details

Units Affected
5,856 bottles
Distribution
USA nationwide
Location
Mahwah, NJ

Frequently Asked Questions

What product was recalled?
Deferasirox Tablets for Oral Suspension, 500mg, 30-count bottle, Rx only, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, Product of India, NDC 68462-496-30. Recalled by Glenmark Pharmaceuticals Inc., USA. Units affected: 5,856 bottles.
Why was this product recalled?
Failed Dissolution Specifications
Which agency issued this recall?
This recall was issued by the FDA Drug on November 15, 2023. Severity: Moderate. Recall number: D-0095-2024.